South Korea-based GCCL Co., a data-driven clinical trial services provider, and Germany-based Medicover Integrated Clini...
GCCL, a leading South Korea-based provider of clinical trial sample analysis, and US-based OPIS, a global full-service c...
Curie Oncology, one of Southeast Asia's fastest-growing private oncology networks, has partnered with Singapore-based he...
Zuellig Pharma, a leading healthcare solutions company in Asia, has announced the grand opening of its new state-of-the-...
NEXT Oncology, an Avacare business, has expanded its services to Asia through a strategic partnership with Kansai Medica...
The project will modernize Lilly’s facilities in Carolina, generate over 1,100 new jobs across construction and op...
Singapore-based Raffles Medical Group and Gene Solutions, headquartered in Vietnam, have signed a Memorandum of Understa...
Avance Clinical, the Australia-based global CRO partner for biotechs, has announced the launch of its dedicated Early Ph...
Expecto Health Science, an emerging Asia-Pacific Contract Research Organisation (CRO) led by a highly experienced leader...
Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industr...
Verified Clinical Trials (VCT), the global leader in clinical trial subject registry solutions, has officially laun...
Novatrials, Australia’s largest independently owned clinical trials site, is excited to announce its newly constru...
The Public Health Systems Research Institute (PHRI) and Novo Nordisk Pharma (Thailand) Co. have signed a major...
Australia-headquartered Telix Pharmaceuticals has established Telix Manufacturing Solutions (TMS) in Yokohama, Japan. Te...
To accelerate clinical trial activation and execution, enhance research quality, and strengthen international competitiv...
Teddy Laboratory, a subsidiary of Tigermed, has officially signed a strategic cooperation agreement with LabConnect...
Patients with non-proliferative diabetic retinopathy (NPDR) currently face a therapeutic gap—one that often leaves...
Researchers at The University of Queensland (UQ), Australia have dosed 5 participants in the first clinical trial of a p...
What are the company’s major plans in store for 2025, particularly for the APAC region? The pharmaceutical ...
Novotech, a global leading full-service clinical Contract Research Organization (CRO), and Acrostar, a provider of Site ...
Avance Clinical, a leading full-service global Contract Research Organization (CRO) specialising in high-quality, agile ...
The China Medical University Hospital Clinical Trial Center (CMUH-CTC) is committed to enhancing clinical trials within ...
Trade and Investment Queensland (TIQ), the Queensland Government’s dedicated business agency presented a 20 member...
Brexogen, a leading biotechnology company specialising in exosome-based therapeutics, has announced a technology transfe...
Novotech, a global full-service clinical Contract Research Organisation (CRO) that partners with biotech and small to mi...
South Korea-based OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, has announced a global licensing...
The Australian Government is investing close to $20 million in funding for researchers to support groundbreaking nationa...
When almost half of clinical trial stakeholders describe their working relationships as "complicated," it’s a sign...
Kazia Therapeutics Limited , an oncology-focused drug development company, has announced the regulatory approval and lau...
National Taiwan University Hospital (NTUH) and AbbVie Biopharmaceuticals GmbH Taiwan Branch (AbbVie) have signed a coope...
Harvest Integrated Research Organization (HiRO), a boutique global clinical research organization (CRO) providing c...
Can you elaborate on Medidata’s growth strategy for the APAC region? What specific factors are driving the expansi...
The US Food and Drug Administration (FDA) has just approved the second drug in the past two years that’s currently...
The Life Sciences Industry: Pitfalls and the Impact of Failed Clinical Trials in 2024 The life sciences industry is at ...
Longstanding alliance between Evotec and CHDI to enable the development of therapeutics for Huntington’s disease...
To mark World Clinical Trials Day on May 20, Victorian Deputy Premier and Minister for Medical Research, Ben Carro...
Could you elaborate on some of the most prominent trends shaping the landscape of clinical trials in the Asia-Pacific re...
Making its triumphant return to the region this Summer, this meeting will bring together key players of the ADC lan...
Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-M...
What makes Uvax Bio’s technology different from other vaccine technologies? Recombinant protein vaccines ar...
Could you elaborate on the most prominent trends shaping the APAC clinical trials landscape? One of Lokavant’s ea...
While the increasing volume of clinical data is welcome in many respects, clinicians and trial managers often struggle w...
Over the past decade, the Asia-Pacific (APAC) region has emerged as a global leader in clinical trial conduct. In 2021, ...
The APAC region continues to rule the roost in clinical trials, experiencing dramatic growth rates surpassing those in t...
Australian Translational Genomics Centre (ATGC) at Queensland University of Technology (QUT) will help link Queensland...
A team of healthcare professionals has received a $50,000 award to transform their idea for an Artificial Intelligence (...
ClinChoice, a global Contract Research Organisation (CRO), has announced expanding its global footprint with the acquisi...
The Coalition for Epidemic Preparedness Innovations (CEPI), the Republic of Korea-based International Vaccine Institute ...
US-based Lokavant, the clinical trial intelligence platform company, has announced an $8 million strategic investment fr...
Buzzreach and Oncoshot, two prominent entities in the clinical trials domain, have announced an impactful collaboration ...
An examination of how clinical trials have changed in Australia over the past 15 years has identified challenges such as...
According to a February 2022 report by Research and Markets, the clinical trials market in India was estimated to be val...
Biosyngen, an immuno-oncology company with technology targeting the unmet medical needs in solid tumour and lymphoma tre...
Cyteph, a spin-out biotechnology company from QIMR Berghofer Medical Research Institute in Australia, has been awa...
Singapore-based startup Hummingbird Bioscience has entered into a clinical trial collaboration and supply agreement with...
How do you define the essentials of a decentralised approach in the current drug discovery landscape? It is essential t...
Omi Medical Center, a part of the Seikoukai Social Medical Corporation and one of Japan's leading institu...
In collaboration with US-based Kiora Pharmaceuticals, Inc. and The Royal Adelaide Hospital, leading Australian Contract ...
Australian biotech firm Vaxxas has announced the initiation of a Phase I clinical trial with the first inactivated ...
South Korean firm Wellmarker Bio (WMBIO) has entered a clinical trial collaboration and supply agreement with Merck (kno...
Australia's CardieX Limited, a global health technology company focused on patient-centric healthcare research and impro...
P3 Research, a leading New Zealand (NZ) clinical trials site network with seven locations across New Zealand, has t...
New Zealand's leading health agencies will explore system-level changes to improve benefits from clinical trials, based ...
Singapore-based startup Oncoshot and internationally recognised contract research organisation (CRO) Novotech have begun...
China-based startup Jacobio has entered into a clinical trial collaboration agreement with Merck on clinical study of co...
A multi-national, investigator-initiated and industry-backed clinical trial has been launched to test the efficacy of a ...
The Asia Pacific (APAC) region has taken in the lead in cell and gene clinical trials, accounting for the largest share ...
Australia-based Alterity Therapeutics has announced that the company’s Phase 2 clinical trial of ATH434 for ...
Hematogenix, the first central oncology laboratory for clinical trials in Malaysia has been officiated by the Minister o...
Crux Biolabs, a leading Australian laboratory for vaccines, immunotherapies, immuno-oncology and infectious diseases, ha...
Japan-based Aculys Pharma has entered into a contract with SUSMED, Inc., a company that promotes digital medicine, to co...
Singapore-based AUM Biosciences has entered into a clinical trial collaboration and supply agreement with Roche to evalu...
Genome and Company, a leading global microbiome anti-cancer drug development company in Korea, has entered into a first ...
Shanghai Public Health Clinical Centre and Cheng Kung University's Department of Microbiology and Immunology have joined...
ObvioHealth, a global Virtual Research Organization (VRO), is set to launch a first-of-its-kind clinical trial in A...
Futura Medical, a pharmaceutical company developing a portfolio of innovative products based on its proprietary, transde...
A £1.5 million grant from the UK's Medical Research Council (MRC) will support new research examining changes in h...
Zhaoke Ophthalmology has announced that the Phase III clinical trial of one of the company's core drug candidates, Cyclo...
Clinical trials in a drug development process often face multiple hurdles around patient recruitment and management resu...
Universities of Sheffield, Oxford, Liverpool, Newcastle, and Birmingham, with support from the UK Coronavirus Immunology...
Beneficial effects in autism spectrum disorders of the Japanese food supplement Nichi-Glucan (www.nichiglucan.com), a bi...
eTheRNA immunotherapies, a clinical-stage company developing mRNA-based immunotherapies for the treatment of cancer and ...
Medidata, a Dassault Systèmes company, announced the launch of the Medidata Decentralized Clinical Trials (D...
The International Vaccine Institute (IVI) in South Korea has announced that the Bill & Melinda Gates Foundation has ...
Tiziana Life Sciences plc, a UK based biotechnology company focused on innovative therapeutics for oncology, inflammatio...
Guangzhou Link Health Pharma Co., Ltd. (Link Health), based in China, and Australian firm George Clinical Pty Ltd (Georg...
FUJIFILM Toyama Chemical has announced the initiation of a new phase III clinical trial in Japan concerning its anti-inf...
TrialWire(TM), the most secure digital Patient Recruitment Platform for trial rescue, announces the launch of StudyBoost...
United Kingdom government announced an investment of 33.6 million pounds ($43.5 million) in a study called “h...
Panthera’s clinical trial sites in Preston, North Manchester and North London began dosing volunteers in the Phase...
In June 2020, Tychan began its Phase 1 clinical safety trials in humans to evaluate TY027, a monoclonal antibo...
Croda International Plc (“Croda” or “the Group”), the speciality chemical company that uses smar...
CEPI, the Coalition for Epidemic Preparedness Innovations, based in Norway, has announced that it will fund the developm...
Asian biotech industry has been experiencing an escalating boom over the past several years. Pharmaceutical companies ha...
Daewoong Pharmaceutical announced on 26 Oct 2020 that the collaborative clinical research agreement betwe...
Asieris Pharmaceuticals, a China-based biotech company specializing in the development and commercialization of new...
APRINOIA Therapeutics advancing a pipeline featuring diagnostic and therapeutic programs, collectively targeting brain d...
The COVID Pandemic has dramatically disrupted the delivery of clinical trials. Sponsors now require instant access...
ORIC Pharmaceuticals, Inc., a clinical-stage oncology company focused on developing treatments that address mechanisms o...
Japan-based Astellas Pharma Inc. (Astellas) has announced that in collaboration with FibroGen and AstraZeneca, 42 roxadu...
